Practical consensus recommendation on when to do BRCA testing
| Autor: | S Aggarwal, S Mittal, S Ranjan, M Ahmed, J Wadhwa, Randeep Singh, S. P. Kataria, Prashant Mehta, Purvish M. Parikh, S Salim, Ajay Gupta, S Minhas |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Cancer Research
medicine.medical_specialty animal structures endocrine system diseases Brca testing lcsh:RC254-282 03 medical and health sciences 0302 clinical medicine Breast cancer medicine Family history skin and connective tissue diseases Genetic testing family history prostate medicine.diagnostic_test business.industry BRCA mutation Cancer extended germline mutation medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens female genital diseases and pregnancy complications ovarian cancer paternal history Oncology age 030220 oncology & carcinogenesis Family medicine pancreatic 40 years Original Article business Large group Ovarian cancer 030215 immunology |
| Zdroj: | South Asian Journal of Cancer South Asian Journal of Cancer, Vol 7, Iss 2, Pp 106-109 (2018) |
| ISSN: | 2278-4306 2278-330X |
| Popis: | BRCA-mutation associated breast cancer and to future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for BRCA1 and BRCA2 mutations is available, BRCA mutation status can be considered when making treatment and prevention decisions for BRCA testing, BRCA mutation carriers with breast cancer. Expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|